Healthtech funding in Q3 2016
European Healthtech startup funding raised during Q3 2016.
In Q3 2016, 71 European Healthtech companies closed 73 funding rounds and raised €393M in equity funding (excluding debt and grants), down 45.2% versus Q3 2015. Debt rounds added €1.0M. Germany led by capital raised, and Bayern Kapital was the most active investor. Data as of 20 Nov 2026.
Equity funding
€393M
-45.2% vs Q3 2015 · excl. debt & grants · +€1.0M debt
Funding rounds
73
+19.7% vs Q3 2015
Companies
71
Top country
Germany
Rank among sectors
#4
6.9% of sector funding
Debt financing
€1.0M
0.2% of total
Top-10 round share
61.5%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q3 2016 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €181M | 26 |
| Aug | €34M | 17 |
| Sep | €182M | 30 |
Top countries
by € raisedHealthtech — top countries by capital, Q3 2016 — interactive chart.
Data table
| Healthtech — top countries by capital, Q3 2016 | |
|---|---|
| Germany | €106M |
| UK | €83M |
| Ireland | €37M |
| Switzerland | €35M |
| Israel | €30M |
| France | €25M |
| Sweden | €21M |
| Netherlands | €21M |
Stage mix
by € raisedHealthtech — stage mix, Q3 2016 — interactive chart.
Data table
| Healthtech — stage mix, Q3 2016 | |
|---|---|
| Series A | €162M |
| Growth/Late | €100M |
| Series B | €84M |
| Series C | €21M |
| Early VC | €19M |
| Seed | €8.2M |
| Grant | €2.4M |
| Debt | €1.0M |
Exits & M&A
6 Acquisition · 2 IPO8 exits · €82M disclosed.
| Creo Medical | IPO | Jul 2016 | €74M |
| Cellink | IPO | Aug 2016 | €8.1M |
Top deals
largest disclosed rounds in Q3 2016| Company | Stage | Date | Amount |
|---|---|---|---|
| Brillen.de | Growth/Late | Jul 2016 | €45M |
| IOmx Therapeutics | Series A | Sep 2016 | €40M |
| Spineart | Growth/Late | Sep 2016 | €30M |
| Artios | Series A | Sep 2016 | €29M |
| Cambridge Medical Robotics | Series A | Jul 2016 | €18M |
| Aspect Imaging | Growth/Late | Jul 2016 | €18M |
| Nyxoah | Series B | Jul 2016 | €18M |
| Vivasure Medical | Series C | Sep 2016 | €16M |
| Inflazome | Series A | Sep 2016 | €15M |
| Rigontec | Series A | Sep 2016 | €14M |
| NightBalance | Series B | Jul 2016 | €13M |
| Big Health | Series B | Jul 2016 | €11M |
| Lifesum | Series B | Jul 2016 | €9.1M |
| ImmunArray | Series B | Jul 2016 | €9.1M |
| Eyevensys | Series A | Sep 2016 | €9.0M |
Top investors
most active in Q3 2016, by deal count- Bayern Kapital3 deals
- BGF2 deals
- Fountain Healthcare Partners2 deals
- Gilde Healthcare2 deals
- Imperial Innovations Limited2 deals
- Index Ventures2 deals
- Inkemia2 deals
- Innogest Capital2 deals
- Life Sciences Partners2 deals
- NSA Ventures2 deals